Sunny Kumar Partner
Sunny Kumar is a Partner at GSR Ventures, where he focuses on investments in early-stage companies applying artificial intelligence and machine learning technologies to the healthcare sector. Prior to GSR Ventures, Sunny was an investor with the Stanford GSB Impact Fund, empowering high-impact healthcare startups, and he worked at Longitude Capital developing an investment thesis into gene and cell therapies. Sunny received a BS in Molecular Biology from Yale University, an MD from Stanford University School of Medicine, and an MBA from Stanford University Graduate School of Business.
We believe that the biggest problem in healthcare globally is the spread of infectious illness. The key to stopping the spread is better information on where and when it is starting. It is unacceptable that, in 2020, tens of thousands of lives are lost every year to the seasonal flu – an illness that we know will come each year, yet each year we are unprepared to mobilize the right resources in the right places at the right times. We believe we can change this story. Our mission is to stop the spread of contagious illness, from the flu to Covid-19, through earlier detection and earlier response.
Deep 6 AI applies artificial intelligence and natural language processing to all clinical data to find eligible patients for clinical trials in minutes rather than months, getting life-saving cures to people more quickly. Deep 6 AI got its start by beating out some of the biggest names in analytics in a U.S. government-sponsored competition. This led to a contract with the U.S. intelligence community, which is perhaps the most complex data environment in the world. Since 2016, Deep 6 AI has focused exclusively on healthcare, participating in the Cedars-Sinai Accelerator Powered by Techstars, the Healthbox modified-accelerator program, and Stanford’s StartX Accelerator.
Medable is on a mission to reduce clinical trial timelines by 50 percent. The company’s global decentralized trial platform streamlines design, recruitment, retention and data quality, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes.
STE. 5620, China World Trade Center Tower III
No.1 Jianguomenwai St., Chaoyang Dist.
Beijing, 100004, China
Silicon Valley Office:
245 Lytton Ave
Palo Alto, CA 94301, USA
Tel: +1 (650) 331-7300
1 George Street
©2020 GSR Ventures. All Rights Reserved.